News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News EU regulators back two more orphan drugs, question of pricin... Two orphan medicines are heading towards the European market, after regulators recommended rare disease drugs from Biogen and BioMarin.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Apitope aims to bounce back from MS setback Biotech looks for funding and long-term development partner
News Celgene to file potential MS blockbuster this year Success with ozanimod would justify $7.2 billion outlay for Receptos.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
